Table 3.

Effects of American Diabetes Association (ADA) diet and ADA diet + rosuvastatin on somatic and autonomic nerve function

Nerve function measures	Pre-treatment (n = 16)	ADA diet (n = 16)	ADA diet + rosuvastatin (n = 16)
Sural amplitude	8.43 ± 1.60*	7.33 ± 1.25	8.68 ± 1.48
Sural CV	39.12 ± 2.75	36.90 ± 3.78	36.06 ± 3.59
Peroneal amplitude	4.06 ± 0.68	4.08 ± 0.68	3.97 ± 0.68
Peroneal CV	41.69 ± 1.20	42.35 ± 1.21	41.96 ± 1.58
Vibration	16.59 ± 2.77	18.81 ± 4.37	19.93 ± 4.10
Pressure	3.53 ± 0.22	3.47 ± 0.18	3.64 ± 0.22
Cold sensation	6.41 ± 0.91	6.16 ± 0.95	6.16 ± 0.93
Warm sensation	7.96 ± 1.07	6.96 ± 1.03	7.61 ± 1.04
Cold pain	17.56 ± 3.86	18.78 ± 3.61	19.68 ± 3.11
Heat pain	15.17 ± 0.95	14.67 ± 1.15	13.15 ± 0.93
E/I ratio	1.26 ± 0.14	1.14 ± 0.03	1.20 ± 0.08
Valsalva ratio	1.25 ± 0.05	1.23 ± 0.06	1.57 ± 0.31
30/15 ratio	3.81 ± 1.29	3.97 ± 0.93	2.86 ± 0.57

Abbreviations: CV, conduction velocity; autonomic function measures of heart rate variability during: E/I ratio, expiration/inspiration ratio; Valsalva ratio, Valsalva maneuver (forcible exhalation against a closed airway); 30/15 ratio, electrocardiogram R-R interval to upright posture.